secwatch.observer — SEC 8-K summary
======================================

Issuer:     VBI Vaccines Inc/BC (—)
CIK:        0000764195
Form:       8-K
Filed at:   2024-04-11T23:59:59+00:00
Accession:  0001493152-24-014323
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VBI Vaccines raises $2M in registered direct offering; discloses $23.7M cash as of Dec 31, 2023
--------------------------------------------------------------------------------

- Sold 2,272,728 common shares at $0.88 each with warrants to buy same at $0.76, 5-year term.
- Net proceeds ~$1.7M after placement agent fees; funds for working capital and general corporate purposes.
- Preliminary unaudited cash balance as of Dec 31, 2023: approximately $23.7M.
- Offering closed April 11, 2024; H.C. Wainwright acted as exclusive placement agent.
- Placement agent received warrants for 136,364 shares at $1.10 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/764195/000149315224014323/0001493152-24-014323-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/764195/000149315224014323/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-014323

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer